Rocket Pharmaceuticals (RCKT) Accumulated Expenses (2013 - 2021)
Rocket Pharmaceuticals' Accumulated Expenses was $2.37 million in Q4 2017, down 44.1% from $4.25 million a year earlier and down 18.2% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Accumulated Expenses (2013 - 2021) Analysis & Trends
From Q4 2014 onward, Rocket Pharmaceuticals has reported Accumulated Expenses for 13 quarters.
- Accumulated Expenses shows a three-year compound annual growth rate of 33.7% (FY2014 to FY2017).
- In earlier years, Accumulated Expenses was $4.25 million in FY2016 (+69.3%), $2.51 million in FY2015 (+152.8%) and $992,000 in FY2014.
- The Q4 2017 figure marks the lowest quarterly Accumulated Expenses since Q3 2015.
- Compared with a year earlier, Accumulated Expenses has declined for four straight quarters, with growth averaging 58.3% over the last eight quarters.
- The best year-over-year quarter for Accumulated Expenses over five years was Q1 2016 (growth of 207.8%); the worst was Q4 2017 (a decline of 44.1%).
- Per Business Quant data, RCKT's Accumulated Expenses in the three quarters before Q4 2017 was $2.9 million (Q3 2017), $2.42 million (Q2 2017) and $2.89 million (Q1 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Rocket Pharmaceuticals | 268.37 Mn | -15.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 123,000.00 |
| Mar 31, 2021 | 449,000.00 |
| Dec 31, 2020 | 1.12 Mn |
| Sep 30, 2020 | 620,000.00 |
| Jun 30, 2020 | 1.25 Mn |
| Mar 31, 2020 | 500,000.00 |
| Dec 31, 2019 | 1.24 Mn |
| Sep 30, 2019 | 493,000.00 |
| Jun 30, 2019 | 1.24 Mn |
| Mar 31, 2019 | 493,000.00 |
| Dec 31, 2018 | 1.24 Mn |
| Sep 30, 2018 | 493,000.00 |
| Jun 30, 2018 | 1.24 Mn |
| Mar 31, 2018 | 493,000.00 |
| Sep 30, 2017 | 3.38 Mn |
| Jun 30, 2017 | 3.65 Mn |
| Mar 31, 2017 | 3.37 Mn |
| Dec 31, 2016 | 5.45 Mn |
| Sep 30, 2016 | 4.17 Mn |
| Jun 30, 2016 | 3.15 Mn |
API Access
Rocket Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();